Why Axsome Therapeutics Stock Reaches Another High
Axsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
Track income, expenses, savings, and debt payments to gain a clear view of your financial health and progress.
16,643 articlesAxsome Therapeutics stock keeps climbing, hitting another high as regulatory news and a solid quarterly update bolste...
A sizable early-2026 investment in a gold-focused miner is turning heads. This article breaks down what it could mean...
A sizable move in the First Trust QTEC fund has traders buzzing. Is the sale a warning sign for overheated AI stocks ...
With Trump heading to China for high-stakes talks, Goldman Sachs flags a dollar overvaluation of roughly 12-15% versu...
As Uniti maps out its path for 2026, investors want clarity on revenue, cash flow, and growth prospects. This guide b...
Investors are watching Health Catalyst as healthcare data analytics gain budget priority. This guide breaks down what...
As 2026 accelerates, a wave of deals reshapes the cybersecurity landscape. Analysts spotlight targets likely to be ac...
Citi boosts its Broadcom price target to $500 on expectations of solid AI-driven revenue in the upcoming April quarte...
Sagent rolled out AI-enabled updates to the Dara platform at Ignite, signaling a shift toward AI-driven mortgage serv...
Bitcoin climbs as aggressive spot demand sweeps in, lifting BTC to multi-week highs while U.S. data tests trader nerv...
Open Society Foundations committing $30 million over three years to support interfaith partnerships and protect commu...
After a steep slide, Novo Nordisk has shown fresh momentum. But can the rebound sustain, or is it just a temporary bo...